GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (BOM:524494) » Definitions » Price-to-Free-Cash-Flow

Ipca Laboratories (BOM:524494) Price-to-Free-Cash-Flow : N/A (As of May. 13, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Ipca Laboratories Price-to-Free-Cash-Flow?

As of today (2024-05-13), Ipca Laboratories's share price is ₹1297.75. Ipca Laboratories's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.00. Hence, Ipca Laboratories's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Ipca Laboratories's Price-to-Free-Cash-Flow or its related term are showing as below:

BOM:524494' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 0   Med: 48.57   Max: 225.75
Current: 107.12

During the past 13 years, Ipca Laboratories's highest Price-to-Free-Cash-Flow Ratio was 225.75. The lowest was 0.00. And the median was 48.57.

BOM:524494's Price-to-Free-Cash-Flow is ranked worse than
89.44% of 502 companies
in the Drug Manufacturers industry
Industry Median: 22.695 vs BOM:524494: 107.12

Ipca Laboratories's Free Cash Flow per Share for the three months ended in Dec. 2023 was ₹0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ₹0.00.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 5.50% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 10.70% per year.

During the past 13 years, Ipca Laboratories's highest 3-Year average Free Cash Flow per Share Growth Rate was 94.70% per year. The lowest was -11.50% per year. And the median was 15.10% per year.


Ipca Laboratories Price-to-Free-Cash-Flow Historical Data

The historical data trend for Ipca Laboratories's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipca Laboratories Price-to-Free-Cash-Flow Chart

Ipca Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 38.73 66.47 33.07 71.39 66.03

Ipca Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 66.03 - - -

Competitive Comparison of Ipca Laboratories's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Ipca Laboratories's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ipca Laboratories's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ipca Laboratories's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Ipca Laboratories's Price-to-Free-Cash-Flow falls into.



Ipca Laboratories Price-to-Free-Cash-Flow Calculation

Ipca Laboratories's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=1297.75/0
=N/A

Ipca Laboratories's Share Price of today is ₹1297.75.
Ipca Laboratories's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Ipca Laboratories  (BOM:524494) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Ipca Laboratories Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Ipca Laboratories's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Ipca Laboratories (BOM:524494) Business Description

Traded in Other Exchanges
Address
125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Ipca Laboratories Ltd is a specialty and generic drug manufacturing company. The company's principal activity is Development, Manufacturing and Marketing of Pharmaceuticals Products. The company operates multiple subsidiaries with revenue generation split roughly between India and the rest of the world. Ipca's products are exported to more than 100 countries across the globe. Ipca has only one reportable primary business segment, pharmaceuticals.

Ipca Laboratories (BOM:524494) Headlines

No Headlines